Jean-Luc Plassat
French Institute of Health and Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean-Luc Plassat.
The EMBO Journal | 1992
Jean-Luc Plassat; Ursula Boschert; Nourdine Amlaiky; René Hen
Serotonin (5‐HT) is a neuromodulator that mediates a wide range of physiological functions by activating multiple receptors. Using a strategy based on amino acid sequence homology between 5‐HT receptors that interact with G proteins, we have isolated a cDNA encoding a new serotonin receptor from a mouse brain library. Amino acid sequence comparisons revealed that this receptor was a distant relative of all previously identified 5‐HT receptors; we therefore named it 5HT5. When expressed in Cos‐7 cells and NIH‐3T3 cells, the 5HT5 receptor displayed a high affinity for the serotonergic radioligand [125I]LSD. Surprisingly, its pharmacological profile resembled that of the 5HT1D receptor, which is a 5‐HT receptor subtype which has been shown to inhibit adenylate cyclase and which is predominantly expressed in basal ganglia. However, unlike 5HT1D receptors, the 5HT5 receptor did not inhibit adenylate cyclase and its mRNA was not found in basal ganglia. On the contrary, in situ hybridization experiments revealed that the 5HT5 mRNA was expressed predominantly in cerebral cortex, hippocampus, habenula, olfactory bulb and granular layer of the cerebellum. Our results therefore demonstrate that the 5HT1D receptors constitute a heterogeneous family of receptors with distinct intracellular signalling properties and expression patterns.
Journal of Biological Chemistry | 2005
Gaétan Bour; Jean-Luc Plassat; Annie Bauer; Sébastien Lalevée; Cécile Rochette-Egly
Nuclear retinoic acid receptors (RARs) are ligand-dependent transcription factors that regulate the expression of retinoic acid target genes. Although the importance of RAR phosphorylation in their N-terminal domain is clearly established, the underlying mechanism for the phosphorylation-dependent transcriptional activity of the receptors had not been elucidated yet. Here, using a yeast two-hybrid system, we report the isolation of vinexin β as a new cofactor that interacts with the N-terminal A/B domain of the RARγ isotype. Vinexin β is a multiple SH3 motif-containing protein associated with the cytoskeleton and also present in the nucleus. We demonstrate that vinexin β colocalizes with RARγ in the nucleus and interacts with the non-phosphorylated form of the AF-1 domain of RARγ. We also show that this interaction is prevented upon phosphorylation of the AF-1 domain. Using F9 cells stably overexpressing vinexin β or vinexin knockdown by RNA interference, we demonstrate that vinexin β is an inhibitor of RARγ-mediated transcription. We propose a model in which phosphorylation of the AF-1 domain controls RARγ-mediated transcription through triggering the dissociation of vinexin β.
Molecular Pharmacology | 1993
Jean-Luc Plassat; Nourdine Amlaiky; R. Hen
Molecular Pharmacology | 1993
H. W. Matthes; Ursula Boschert; Nourdine Amlaiky; Régis Grailhe; Jean-Luc Plassat; Françoise Muscatelli; M. G. Mattei; René Hen
Journal of Biological Chemistry | 1992
N Amlaiky; S Ramboz; U Boschert; Jean-Luc Plassat; R. Hen
Cellular Signalling | 2005
Nathalie Bruck; Julie Bastien; Gaétan Bour; Anne Tarrade; Jean-Luc Plassat; Annie Bauer; Sylvie Adam-Stitah; Cécile Rochette-Egly
Archive | 1993
Nourdine Amlaiky; Ursula Boschert; R. Hen; Jean-Luc Plassat
Archive | 1993
Nourdine Amlaiky; Ursula Boschert; R. Hen; Jean-Luc Plassat
Archive | 1993
Nourdine Amlaiky; Ursula Boschert; R. Hen; Jean-Luc Plassat
Archive | 1992
Frederic Saudou; Ursula Boschert; Nourdine Amlaiky; Jean-Luc Plassat